Funding awarded
- Partial gene inactivation and pharmacological modulation of Mtb targets (INV-004764) awarded by Bill & Melinda Gates Foundation Key Personnel 2020 - 2023
- Targeting Biotin Metabolism in Mycobacterium Tuberculosis awarded by National Institute of Allergy & Infectious Diseases Key Personnel 2019 - 2023